Furthermore, within the bladder cancer group, the proline/leucine genotype of GPX1 was more prevalent in cases with stage T2-4 tumors compared with Ta-1 tumors, indicating its association with advanced tumor stages [15]. This evidence concerns the gene GPX1 and urinary bladder carcinoma.